0001127602-20-007430.txt : 20200224 0001127602-20-007430.hdr.sgml : 20200224 20200224205414 ACCESSION NUMBER: 0001127602-20-007430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humphries William D. CENTRAL INDEX KEY: 0001674278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 20646941 MAIL ADDRESS: STREET 1: C/O CLEARSIDE BIOMEDICAL, INC. STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-02-19 0000885590 Bausch Health Companies Inc. BHC 0001674278 Humphries William D. 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 President, Ortho-Dermatologics Common Stock, No Par Value 2020-02-19 4 M 0 20911 A 184776 D Common Stock, No Par Value 2020-02-19 4 A 0 105783 0 A 290559 D Common Stock, No Par Value 2020-02-20 4 F 0 56532 26.46 D 234027 D Restricted Share Units 2020-02-19 4 M 0 20911 D Common Stock 20911 0 D Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units ("PSUs") granted to the reporting person on January 2, 2017. On January 2, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. Each PSU converts into Common Shares on a one-for-one basis. This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. This PSU award was previously reported on a Form 4 filed on January 4, 2017 with the maximum potential award amount of 41,002 shares. Any portion of the award not vested on February 19, 2020 was cancelled as of that date. /s/ Kirsten O'Donnell, attorney-in-fact for William D. Humphries 2020-02-24